Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-001132

Director acquired 8,958 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Leftwich Scott Director 2023-12-21 Grant or award +8,958 $1.80 $16,124 469,903 D
Derivatives
Leftwich Scott Director 2023-12-21 Grant or award · Non-Qualified Stock Options (right to buy) +70,249 70,249 D
Loading xslF345X05/ownership.xml…